A Novel Pathway of Insulin Sensitivity in Chromogranin A Null Mice-Reference-Cited by-同舟云学术

A Novel Pathway of Insulin Sensitivity in Chromogranin A Null Mice

Published:2009-10 Issue:42 Volume:284 Page:28498-28509
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Gayen Jiaur R.,Saberi Maziyar,Schenk Simon,Biswas Nilima,Vaingankar Sucheta M.,Cheung Wai W.,Najjar Sonia M.,O'Connor Daniel T.,Bandyopadhyay Gautam,Mahata Sushil K.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference57 articles.

1. The chromogranins A and B: The first 25 years and future perspectives

2. The Chromogranin–Secretogranin Family

3. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

4. Vasostatins, Comprising the N-terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments

5. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Catestatin Levels in Patients with Acne Vulgaris: Single-Center Prospective Study;Skin Appendage Disorders;2024-06-11

2. NADPH Oxidase 3: Beyond the Inner Ear;Antioxidants;2024-02-08

3. Sensitivity of the Neuroendocrine Stress Axis in Metabolic Diseases;Hormone and Metabolic Research;2024-01

4. Serum catestatin levels in patients with acne vulgaris: single-center prospective study;2023-11-14

5. Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-09-07